Table 1. Demographic and epidemiological data of the population studied, resistance profile and biofilm genes in S. aureus isolates from the nostrils of health professionals in the seven units of the Family Health Strategy.
| Variables | Carriers | Non-carriers | TOTAL | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MSSA (N = 13) | MRSA (N = 34) | SCCmec type (%a) | |||||||||
| N | % | N | % | I | III | IV | Not typeable | N | % | N | |
| Profession | |||||||||||
| Community health agents | 4 | 18.2 | 12 | 54.5 | 29.4 | 29.4 | 29.4 | 11.8 | 6 | 27.3 | 22 |
| Social worker | 1 | 100 | - | - | - | - | - | - | - | - | 1 |
| Doctor | - | - | - | - | - | - | - | - | 1 | 100 | 1 |
| Nurses | - | - | 3 | 100 | - | 66.7 | 33.3 | - | - | - | 3 |
| Dentists | - | - | 2 | 66.66 | 50.0 | - | 50.0 | - | 1 | 33.3 | 3 |
| Nursing technicians | 2 | 20.0 | 7 | 70.0 | 12.5 | 37.5 | 50.0 | - | 1 | 10.0 | 10 |
| Dental assistants | - | - | 2 | 66.66 | 50.0 | 50.0 | - | - | 1 | 33.3 | 3 |
| Pharmacists | - | - | 1 | 50,0 | - | - | 100 | - | 1 | 50.0 | 2 |
| Pharmacy attendants | 1 | 20.0 | 2 | 40.0 | 33.3 | 33.3 | 33.3 | - | 2 | 40.0 | 5 |
| Administrative assistant | - | - | - | - | - | - | - | - | 1 | 100 | 1 |
| Receptionists | 2 | 33.3 | 3 | 50.0 | 33.3 | 33.3 | 33.3 | - | 1 | 16.7 | 6 |
| General services | 3 | 60.0 | 1 | 20.0 | - | 100 | - | - | 1 | 20.0 | 5 |
| Uninformed | - | - | 1 | 100 | - | - | 100 | - | - | 1 | |
| Total | 13 | 20.7 | 34 | 53.9 | 24.4 | 34.1 | 36.6 | 4.9 | 16 | 25.4 | 63 |
| Works at another health institution | - | - | 8 | 72.7 | - | 62.5 | 37.5 | - | 3 | 27.3 | 11 |
| Family Health Strategy unity | |||||||||||
| FHS-1 | - | - | 2 | 40.0 | - | 50.0 | 50.0 | - | 3 | 60 | 5 |
| FHS-2 | 3 | 30.0 | 5 | 50.0 | 16.7 | 50.0 | 33.3 | - | 2 | 20 | 10 |
| FHS-3 | 2 | 33.3 | 1 | 16.7 | - | 100 | - | - | 3 | 50 | 6 |
| FHS-4 | 2 | 66.7 | 1 | 33.3 | 100 | - | - | - | - | - | 3 |
| FHS-5 | - | - | 4 | 100 | - | 50.0 | 50.0 | - | - | - | 4 |
| FHS-6 | 1 | 11.1 | 8 | 88.9 | 23.1 | 30.8 | 30.8 | 15.4 | - | - | 9 |
| FHS-7 | 5 | 19.2 | 13 | 50.0 | 35.7 | 21.4 | 42.8 | - | 8 | 30.77 | 26 |
| Comorbidity | 3 | 17.6 | 11 | 64.7 | 21.4 | 50.0 | 28.6 | - | 3 | 17.6 | 17 |
| Infection b | |||||||||||
| Upper airways | 4 | 14.3 | 17 | 60.7 | 23.8 | 38.1 | 38.1 | - | 7 | 25.0 | 28 |
| Skin | 3 | 100 | - | - | - | - | - | - | - | - | 3 |
| Urinary | - | - | 6 | 100 | 10.0 | 40.0 | 30.0 | 20.0 | - | - | 6 |
| Antimicrobial b | |||||||||||
| β-lactams | 6 | 22.2 | 15 | 55.6 | 22.2 | 27.8 | 38.9 | 11.1 | 6 | 22.2 | 27 |
| Macrolid | 3 | 25 | 6 | 50.0 | 16.7 | 33.3 | 50.0 | - | 3 | 25.0 | 12 |
| Quinolone | - | - | 2 | 66.7 | - | 33.3 | 66.7 | - | 1 | 33.3 | 3 |
| Hospitalization b | - | - | 3 | 50.0 | 25.0 | 50.0 | 25.0 | - | 3 | - | 6 |
aCalculated over the total number of MRSA isolated strains per profession; bLast 12 months; FHS = Family Health Strategy.